Clinical Research

New Drug Causes Immune System To Kill Hepatitis B Infected Cells In Animal Model

A drug developed by Gilead Sciences and tested in an animal model at the Texas Biomedical Research Institute in San Antonio suppresses hepatitis B virus infection by stimulating the immune system and inducing loss of infected cells.   ...

Article - News Staff - Apr 28 2013 - 3:00pm

Clinical Trial of Oxytocin for Migraines

Trigemina, a company focused on creating non-narcotic pain relief drugs, is enrolling patients in a Phase II clinical trial of inhaled oxytocin to treat chronic migraine. Trigemina's oxytocin product, known as T1-001 (no doubt to be renamed to someth ...

Blog Post - Susan Kuchinskas - Apr 28 2013 - 11:14am

2-Year-Old Gets Trachea Transplant, Made From Her Own Stem Cells

If you read THE WIRED WORLD IN 2013 Annual Trend Report you may have seen my article predicting we would make a big advancement on the road to growing one of the Big 5 organs from a person's own stem cells this year.  That will mean no more driver ...

Blog Post - Hank Campbell - Apr 30 2013 - 6:02pm

Late Breaking Clinical Trial Results At ERA-EDTA Congress 2013

Nearly 10,000 participants are in Istanbul at  the congress of the ERA-EDTA (European Renal Association- European Dialysis and Transplant Association) to share their knowledge and discuss the latest research findings. New pioneering studies have been pres ...

Article - News Staff - May 22 2013 - 8:00am

Male Menopause 4X More Common In Men With Heart Failure

As men get older they are more likely to suffer from andropausal syndrome (AS), also known as 'menopause' and by other complicated terms 'androgen deficiency in the aging male' or' late-onset hypogonadism'. Men with andropaus ...

Article - News Staff - May 26 2013 - 1:00pm

Split Liver Transplants As Safe As Whole Organ For Young Children

When a liver from a deceased adult or adolescent donor is split into two separate portions for transplantation, with the smaller portion going to a young child and the larger to an adult, the child will benefit as much if they had received a whole organ f ...

Article - News Staff - Jun 10 2013 - 11:00am

Smoking Linked To Adverse Neurosurgical Outcomes

Long-term cigarette smoking impacts morbidity and mortality, no question about that, but there may be a good reason to stop smoking in the weeks before surgery even if you don't intend to quit overall.  In a review article, researchers from the Unive ...

Article - News Staff - Jun 18 2013 - 10:52am

Top-Line Results From ASSURE Clinical Trial

Resverlogix Corp. has announced that its Phase 2b ASSURE clinical trial evaluating RVX-208 in high-risk cardiovascular patients with low high-density lipoprotein (HDL) did not meet its primary endpoint of a-0.6% change in percent atheroma volume as determi ...

Article - News Staff - Jun 30 2013 - 12:18pm

Positive Results Of 3002 Study: LCP-Tacro

Veloxis Pharmaceuticals announced that LCP-Tacro successfully demonstrated non-inferiority compared to tacrolimus (Prograf®; Astellas Pharma) in its Phase III clinical trial, Study 3002. The Phase III randomized, double-blind and double-dummy study in 543 ...

Article - News Staff - Jul 7 2013 - 7:46pm

Wiskott-Aldrich Syndrome: Lentivirus Gene Therapy Helps 3 Kids

An international team that developed a new gene therapy approach to treatment of Wiskott-Aldrich Syndrome, a fatal inherited form of immunodeficiency has reported results. Wiskott-Aldrich Syndrome is a disorder that weakens the body's immune system. ...

Article - News Staff - Jul 11 2013 - 5:33pm